Skip to main content


Browse the latest news, expert commentary, and educational content on lupus.


23-03-2021 | COVID-19 | News

Lupus ‘may impact’ COVID-19 prognosis

A French nationwide study has described COVID-19 outcomes in patients with systemic lupus erythematosus.

12-01-2021 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine

Alfred Kim talks about the initial promise of hydroxychloroquine for COVID-19 and why it did not stand up to later scrutiny (13:06).

06-01-2021 | Systemic lupus erythematosus | News

Hydroxychloroquine blood monitoring may predict thrombosis risk in SLE

Among patients with systemic lupus erythematosus receiving treatment with hydroxychloroquine, low drug levels in the blood are associated with an elevated risk for arterial and venous thrombosis events, researchers report.

More on lupus treatments

29-03-2021 | Lupus nephritis | News

EMA recommends approval of belimumab for lupus nephritis

Click through for more information on this expanded indication

25-03-2021 | Lupus nephritis | News

High prednisone dose, rapid tapering may be favorable in new-onset lupus nephritis

Patients with new-onset lupus nephritis may be more likely to achieve a complete renal response if initially given a higher dose of prednisone than currently recommended, findings indicate.

Keep up with podcasts on this topic, available on

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox

Image Credits